Point-of-care testing

BD has extensive research and production experience in developing near-patient testing solutions for rapidly detecting a wide range of pathogens including respiratory syncytial virus (RSV), influenza A+B and group A streptococcus (GAS).

BD Veritor™ Plus system

BD Veritor™ Plus system

The BD Veritor Plus system is a digital immunoassay (DIA), which is a category of testing that provides lab-quality test results for point-of-care testing within minutes.

BD Veritor™ system

BD Veritor™ system

The BD Veritor System is a digital immunoassay (DIA), which is a new category of testing that allows you to analyse all that you see, and all that you cannot.

BD Veritor™ System for Rapid Detection of SARS-CoV-2

BD Veritor™ System for Rapid Detection of SARS-CoV-2

The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

1000-BDW-ZA-ZAEN-00867

Go to top